-
The Rowland Institute at Harvard seeks outstanding early-career experimentalists in all fields of science and engineering to establish fully independent research groups in the rich intellectual
-
Postdoc in CRISPR Meta-Analytics and AI for Therapeutic Target Discovery and Priotisation (OT Grant)
(obtained at the call closure time or near completion) in a relevant subject, e.g., bioinformatics, computer science, mathematics, physics, engineering or a related field of science. Proven track record
-
using cutting-edge proximity proteomics, protein engineering, CRISPR genome engineering, computational structural biology, and high-throughput electrophysiological techniques. The postdoc will engage in
-
-organized format. Performs chemical biology and molecular biology experiments including but not limited to recombinant protein production and purification, cell culture, biochemical and cell-based assays
-
, Electrical Engineering, Biomedical Engineering, Statistics, or a related field. Strong background in machine learning, data mining, statistical analysis, and computational modeling; Experience with programming
-
the human population, contributing to variable drug responses and posing an economic burden on healthcare systems (Cell 2018). The Babu Group strives to build and maintain a culture of respect, diversity, and
-
with guidance and maintain efficient laboratory operations. The individual will perform duties in order to meet the goals and objectives of the laboratory. Experience in molecular biology, cell culture
-
, Physics, Engineering, or a related field • Prior experience in modeling viral infections, bacterial infections, and/or immune response dynamics • Experience with parameter estimation techniques and data
-
. Specific duties include tissue culture, flow cytometry, in vivo murine work, genotyping, and other basic molecular biology techniques. The fundamental goal of our research is to understand how the nervous
-
cancer progression. We employ a diverse array of pre-clinical models including cancer cell lines, 3D spheroid cultures, orthotopic xenografts, patient-derived xenografts (PDXs), and genetically engineered